Guardian Pharmacy Services (NYSE:GRDN) Insider Sells $19,928,101.76 in Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN) insider Fred Burke sold 671,432 shares of Guardian Pharmacy Services stock in a transaction on Friday, March 20th. The shares were sold at an average price of $29.68, for a total value of $19,928,101.76. Following the completion of the transaction, the insider owned 840,413 shares in the company, valued at $24,943,457.84. The trade was a 44.41% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Guardian Pharmacy Services Trading Down 3.4%

GRDN stock opened at $34.19 on Friday. The company has a market cap of $2.17 billion, a PE ratio of 44.41 and a beta of 0.86. The stock has a 50-day moving average price of $32.88 and a two-hundred day moving average price of $29.95. Guardian Pharmacy Services, Inc. has a 12-month low of $19.17 and a 12-month high of $38.12.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings data on Wednesday, March 11th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.10. The company had revenue of $397.62 million for the quarter, compared to the consensus estimate of $390.04 million. Guardian Pharmacy Services had a return on equity of 31.64% and a net margin of 3.40%.Guardian Pharmacy Services’s revenue for the quarter was up 17.4% on a year-over-year basis. Equities analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have weighed in on GRDN. Stephens lifted their price target on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an “overweight” rating in a research report on Wednesday, January 14th. UBS Group reissued a “buy” rating on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Oppenheimer raised their target price on shares of Guardian Pharmacy Services from $35.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, March 12th. Zacks Research upgraded shares of Guardian Pharmacy Services from a “hold” rating to a “strong-buy” rating in a report on Wednesday, March 18th. Finally, Truist Financial upped their price target on shares of Guardian Pharmacy Services from $34.00 to $38.00 and gave the stock a “buy” rating in a research report on Thursday, March 12th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $38.00.

Hedge Funds Weigh In On Guardian Pharmacy Services

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Brown Advisory Inc. boosted its holdings in Guardian Pharmacy Services by 5.0% in the 2nd quarter. Brown Advisory Inc. now owns 1,682,476 shares of the company’s stock worth $35,854,000 after acquiring an additional 79,652 shares during the period. Valiant Capital Management L.P. grew its position in Guardian Pharmacy Services by 15.8% in the fourth quarter. Valiant Capital Management L.P. now owns 1,232,463 shares of the company’s stock valued at $37,085,000 after acquiring an additional 167,741 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Guardian Pharmacy Services by 3.3% during the third quarter. Wellington Management Group LLP now owns 1,143,729 shares of the company’s stock valued at $30,000,000 after purchasing an additional 36,072 shares during the period. Franklin Resources Inc. lifted its position in shares of Guardian Pharmacy Services by 8.2% during the third quarter. Franklin Resources Inc. now owns 1,056,240 shares of the company’s stock worth $27,705,000 after purchasing an additional 80,033 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in shares of Guardian Pharmacy Services by 9.1% during the third quarter. Vanguard Group Inc. now owns 1,055,102 shares of the company’s stock worth $27,675,000 after purchasing an additional 88,296 shares in the last quarter.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.